Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1982-06-23
1984-02-07
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
548226, 548227, 568308, C07D26344, A61K 3142
Patent
active
044303378
ABSTRACT:
Hypoglycemic oxazolidine-2,4-diones, substituted at the 5-position with a (C.sub.5 -C.sub.9) unsaturated monocyclic, saturated bicyclic or unsaturated bicyclic hydrocarbon radical; methods for their preparation; and method for their use in the treatment of hyperglycemic mammals.
REFERENCES:
patent: 2338064 (1943-12-01), Stoughton
patent: 2349313 (1944-05-01), Stoughton
patent: 2349795 (1944-05-01), Stoughton
patent: 2349796 (1944-05-01), Stoughton
patent: 2575692 (1951-11-01), Spielman
patent: 2575693 (1951-11-01), Spielman
patent: 2575694 (1951-11-01), Spielman
patent: 2961377 (1960-11-01), Shapiro et al.
patent: 4200642 (1980-04-01), Schnur
patent: 4332952 (1982-06-01), Schnur
patent: 4367234 (1983-01-01), Schnur
Blackwood Robert K.
Daus Donald G.
Frost Albert E.
Gibson S. A.
Knuth Charles J.
LandOfFree
Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2161489